Assessment of the role of microorganisms of respiratory tract in patients with progressive acute respiratory viral infections

Bibliography:
1. Feshchenko Yul, Dzyublik AYa. Ratsional'naya antibiotikoterapiya bol'nykh s infektsiyami nizhnikh dykhatel'nykh putey. UkraTns'kiy pul'monologichniy zhurnal 2009; (4): 5-8
2. Brinbaum HG, Morley М, Greenberg РЕ, et al. Econimic burden of respiratory infections in an employed population. Chest 2002; 122:603-611
3. Detection of influenza virus subtype A by polymerase chain reaction: WHO external quality assessment project summary analysis 2011. Weekly Epidemiological Record 2012; 87: 29-36. http://www.who.int/wer/2012/wer8703/en/index.html (15 August 2013)
4. Orthomyxoviridae. In: Meditsinskaya virusologiya. Moscow: MIA, 2008; p. 176-183
5. Bokavirusy. In: Meditsinskaya virusologiya. Moscow: MIA, 2008; 656 p.
6. Arden КЕ, Nissen MD, Sloots ТР, et al. New coronavirus, HCoV-NL63, associated with lower tract disease in Australia. J Med Virol 2005; (75): 445-462
7. Bastien N, Brandt N, Dust K, et al. Human Bocavirus infection. J Emerg Infect Dis2006; 1.12 (5): 848-850
8. Zapol'skiy AM, Lytkina IN, Mikheeva IV, Bazarova MV Kliniko-epidemiologicheskaya kharakteristika ostrykh respiratornykh virusnykh infektsiy I grippa v epidemicheskikh sezonakh 2008-2009, 2009-2010 and 2010-2011 gg. In: Materialy IV Ezhegodnogo Vserossiyskogo Kongressa po infektsionnym boleznyam. 2012; 10 (1): 147
9. The flu. In: Meditsinskaya virusologiya. Moscow: MIA, 2008; p. 382-393. Russian (Грипп. В кн.: Медицинская вирусология. М.: МИА, 2008; с. 382-393)
10. Chen GW„ Tsao КС, Huang CG, et al. Amino acids transitioning of 2009 H1N1pdm in Taiwan from 2009 to 2011. PLoSOne2012; 7 (9): e45946. doi: 10.1371/journal. pone.0045946
11. Pan'kov AS. Prognozirovanie postgrippoznyh oslozhnenij s uchetom virusno-bakterial'nyh associacij. J epidemiologija i Vakcinoprofilaktika 2012; (6): 21-25
12. Pettigrew М., Laufer AS, Gent JF, et al. Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick children. J Appl EnvironMicrobiol 2012; 78 (17): 6262-6270
13. Rachinskij SV, Tatochenko VK. Bolezni organov dyhanija u detej. Moscow: Meditsina, 1987; p. 232-234. Russian (Рачинский С. В., Таточенко В. К. Болезни органов дыхания у детей. М.: Медицина 1987; с. 232-234)
14. Helminen ME, Maciver I, Latimer JL, et al. A Large, antigenically Conserved Protein on the Surface of Moraxella catarrhalis is a Target for Protective Antibodies. J Infect Dis 1994; (170): 867-872
15. Marrie TJ, Peeling RW, Fine MJ, et al. Ambulatory patients with community-aquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996; (101): 508
16. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process and outcomes in elderly patients with pneumonia. JAMA 1997; (278): 2080-2084
17. Pertseva ТА, Plekhanova OV, Dmitrichenko VV Klinicheski znachimye vozbuditeli infektsiy dykhatel'nykh putey: konspekt vracha-klinitsista i mikrobiologa. Chast' 3: Gemofila. Moraksella. Klinicheskaya immunologiya. Allergologiya. Infektologiya 2007; 6 (1): 15-20
18. Sethi S, Sethi R, Eschberger K, et al. Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; (176): 356-361
19. Abdolrasouli A, Amin A, Baharsefat M, et al. Moraxella catarrhalis associated with acute urethritis imitating gonorrhoea acquired by oralgenital contact. Int J STD AIDS 2007; 18 (8): 579-580
20. Pozdeev OK. Medicinskaja mikrobiologija. Moscow: GJeOTARMEDITSINA, 2001; p.1999-1200
21. Hall-Stoodley L, Costerton JW, Stoodley P. Bacterialbiofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004; (2): 95-108
22. Balder R, Hassel J, Lipski S, et al. Moraxella catarrhalis strain 035E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells. Infect Immun 2007; (75): 2765-2775
23. Bullard B, Lipski S, Lafontaine ER. Regions important for the adhesin activity of Moraxella catarrhalis Hag. ВМС Microbiol 2007; (7): 65
24. Gorter AD, Oostrik J, van der Ley P, et at. Involvement of lipooligosaccharides of Haemophilus influenza and Neisseria meningitidis in defensin-enhanced bacterial adherence to epithelial cells. Microb Pathog 2003; (34): 121-130
25. Akgul GA, Erturk A, Turkoz M, et al. Role of lipooligosaccharide in the attachment of Moraxella catarrhalis to human pharyngeal epithelial cells. J Microbiol Immunol 2005; (49): 931-935
26. Craig L, Pique ME, Tainer JA. Type IV pilus structure and bacterial pathogenicity. Nat Rev Microbiol 2004; (2): 363-378
27. Holm M, Vanlerberg SL, Foley IM, et al. The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells. Infect Immun 2004; (72): 1906-1913
28. Luke N, Jurcisek JA, Bakaletz LO. Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect Immun 2007; (75): 5559-5564
29. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. J Cell 2006; (124): 783-801
30. Attia AS, Lafontaine ER, Latimer JL, et al. The UspA2 protein of Moraxella catarrhalis is directly involved in the expression of serum resistance. Infect Immun 2005; (73): 2400-2410
31. Nordstru,mT, BlomAM, ForsgrenA, etal. The emerging pathogen Moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol 2004; (173): 4598-4606
32. Cossart P, Sansonetti PJ. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 2004; (304): 242-248
33. Spaniol V, Heiniger N, Trailer R, et al. Outer membrane protein UspA1 and lipooligosaccharide are involved in invasion of human epithelial cells by Moraxella catarrhalis. Microbes Infect 2008; (10): 3-11
34. Vries SPW, Bootsma HJ, Hays JP, et al. Molecular Aspects of Moraxella catarrhalis Pathogenesis. Microbiology and Molecular Biology Reviews 2009; 73 (3): 389-406
35. Hodak H, Clantin B, Willery E, et al. Secretion signal of the filamentous haemagglutinin, a model two-partner secretion substrate. Mol Microbiol 2006; (61): 368-382
36. Holme T, Rahman M, Jansson PE, et al. The lipopolysaccharide of Moraxella catarrhalis structural relationships and antigenic properties. Eur J Biochem 1999; (265): 524-529
37. Pearson M, Laurence CA, Guinn SE, et al. Biofilm formation by Moraxella catarrhalis in vitro: roles of the UspA1 adhesin and the Hag hemagglutinin. Infect Immun 2006; (74): 1588-1596
38. Murphy T, Brauer AL, Grant BJ, et al. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 2005; (172): 195-199
39. Bootsma H, van der Heide HG, van de Pas S, et al. Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits. J Infect Dis2000; (181): 1376-1387
40. Budhani RK, Struthers JK. Interaction of Streptococcus pneumoniae and Moraxella catarrhalis: Investigation of the Indirect Pathogenic Role of p-Lactamase-Producing Moraxellae by Use of a Continuous-Culture Biofilm System. Antimicrobial Agents and Chemotherapy 1998; 42(10): 2521-2526.